SCHEMBL2916684

SCHEMBL2916684

O=c1cnc(=O)[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL467460 0.65
SCHEMBL11154028 0.63
SCHEMBL29581682 0.62 ACHE (0.39)
SCHEMBL7443218 0.62
SCHEMBL6526251 0.62
SCHEMBL4422067 0.62
SCHEMBL13863 0.62
SCHEMBL241682 0.62
SCHEMBL312460 0.62
SCHEMBL309070 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973887-B1 AZA HETEROCYCLICS FOR THE TREATMENT OF MALARIA OR AIDS IMMUPHARMA FRANCE SA (FR) 2012-09-19 EP disclosed
US-20100291199-A1 Compositions and Methods For The Treatment and Prevention of Disease CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2010-11-18 US disclosed
US-7777030-B2 Compositions and methods for the treatment and prevention of disease Centre National de la Recherge Scientifique (CNRS) (FR) 2010-08-17 US disclosed
EP-1965806-B1 1, 3, 5-triazepin-2, 6-diones for the treatment of malaria IMMUPHARMA FRANCE SA (FR) 2010-08-11 EP disclosed
EP-1965806-B1 1, 3, 5-triazepin-2, 6-diones for the treatment of malaria IMMUPHARMA FRANCE SA (FR) 2010-08-11 EP disclosed
EP-1973887-A1 AZA HETEROCYCLICS FOR THE TREATMENT OF MALARIA OR AIDS Immupharma France SA (FR) 2008-10-01 EP disclosed
EP-1965806-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF DISEASE IMMUPHARMA FRANCE SA (FR) 2008-09-10 EP disclosed
EP-1289968-B1 CYCLIC UREA COMPOUNDS AND PREPARATION THEREOF CENTRE NAT RECH SCIENT (FR) 2008-02-20 EP disclosed
US-20080033167-A1 Compositions and methods for synthesizing heterocyclic therapeutic compounds UREKA SARL (FR) 2008-02-07 US disclosed
US-20070293469-A1 Compositions and methods for the treatment and prevention of disease UREKA SARL (FR) 2007-12-20 US disclosed
WO-2007074170-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF DISEASE IMMUPHARMA FRANCE SA (FR) 2007-07-05 WO disclosed
WO-2007074171-A1 AZA HETEROCYCLICS FOR THE TREATMENT OF MALARIA OR AIDS IMMUPHARMA FRANCE SA (FR) 2007-07-05 WO disclosed
US-7186828-B2 Cyclic urea compounds and preparation thereof IMMUPHARMA (FRANCE) SA (FR) 2007-03-06 US disclosed
EP-1640368-A2 Cyclic ureas and processes for their preparation The Centre National de la Recherche Scientifique (FR) 2006-03-29 EP disclosed
US-20040044199-A1 Cyclic urea compounds and preparation thereof UREKA SARL (FR) 2004-03-04 US disclosed
EP-1289968-A1 CYCLIC UREA COMPOUNDS AND PREPARATION THEREOF Centre National De La Recherche Scientifique (FR) 2003-03-12 EP disclosed
WO-2001096318-A1 CYCLIC UREA COMPOUNDS AND PREPARATION THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2001-12-20 WO disclosed